Telix Pharmaceuticals TLX
NASDAQ TLX
$9.03 +0.04 (+0.44%)
At close: Oct 27, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Notes Payables (2023 - 2026)

Updated

Telix Pharmaceuticals (TLX) reported Notes Payables of $11.51 million for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Notes Payables (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals posted Notes Payables of $13.11 million, up 11.5% from the prior year.

  • By year, Notes Payables came in at $11.76 million in the year ended Dec 31, 2024 and $660,000 in the year ended Dec 31, 2023.
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Notes Payables since the quarter ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,206.37 Bn 1,174.95 Bn 19.71 Bn
2 Johnson & Johnson 647.04 Bn 566.90 Bn 17.30 Bn
3 AbbVie 506.16 Bn 479.31 Bn 12.70 Bn
4 Merck 349.94 Bn 304.37 Bn 12.21 Bn
5 Novartis Ag 299.20 Bn 272.77 Bn -
6 Astrazeneca 263.53 Bn 237.29 Bn 12.86 Bn
7 Amgen 242.16 Bn 197.56 Bn 7.24 Bn
8 Gilead Sciences 197.42 Bn 171.53 Bn 6.22 Bn
9 Pfizer 169.85 Bn 116.80 Bn 10.94 Bn
10 Telix Pharmaceuticals 3.06 Bn 2.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.51 Mn
Dec 31, 2025 13.11 Mn
Dec 31, 2024 11.81 Mn
Dec 31, 2023 658,055.55
API Access

Telix Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=TLX&period=max&api_key=YOUR_API_KEY